Baylor College of Medicine has announced that Dr. Paul Klotman will retire as president, CEO, and executive dean effective June 30, 2026. The announcement was made following a regular meeting of the Board of Trustees. Dr. Klotman has served in these leadership roles since September 1, 2010.
Greg Brenneman, chair of the Board of Trustees, stated, “Dr. Klotman has done a fantastic job leading BCM. Paul set a clear vision and built an outstanding team to execute it, positioning BCM as a leader in academic medicine. We are very grateful for his many contributions.” He added that the retirement was planned together with Dr. Klotman and expressed confidence in finding a successor who will continue to advance the institution.
Dr. Klotman reflected on his tenure by saying, “I have greatly enjoyed my more than 15 years at Baylor College of Medicine. Even when times were tough, as they were at the beginning of my tenure, I could count on the outstanding faculty, staff and trainees. The people are the strength of this institution, and they will continue to chart its success.”
After nearly five decades in leadership positions at institutions including Baylor College of Medicine, Duke University School of Medicine, the National Institutes of Health and the Icahn School of Medicine at Mount Sinai, Dr. Klotman said he looks forward to focusing on business interests after retirement.
The Board has engaged Hodges Partners to conduct a national search for Dr. Klotman's replacement over the coming weeks.
During Dr. Klotman's time as president and CEO, Baylor College of Medicine’s net assets approached $3 billion while its clinical care programs and research initiatives expanded significantly. The college also saw 50 companies created from its intellectual property and raised $1.4 billion through fundraising efforts.
A retrospective on Dr. Klotman's leadership is available in Baylor College of Medicine's most recent annual report.
